Clinical Trial Update: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma. [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial to assess the safety and preliminary efficacy of QI-019A in relapsed/refractory multiple myeloma; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• QI-019A

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Multiple Myeloma (MM) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING